AMZEEQ
Total Payments
$1.3M
Transactions
15,045
Doctors
4,663
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $32,525 | 5 | 0 |
| 2021 | $671,437 | 7,385 | 2,982 |
| 2020 | $571,973 | 7,655 | 2,533 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $771,720 | 354 | 60.5% |
| Food and Beverage | $330,704 | 14,499 | 25.9% |
| Unspecified | $112,820 | 14 | 8.8% |
| Travel and Lodging | $60,691 | 178 | 4.8% |
Payments by Type
General
$1.2M
15,031 transactions
Research
$112,820
14 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Multicenter, Randomized, Evaluator-Blinded, Study to Evaluate the Safety and Efficacy of AMZEEQ Companion Treatment with Oral Isotretinoin Therapy in Patients with Moderate to Severe Acne Vulgaris | VYNE Pharmaceuticals Inc. | $112,820 | 0 |
Top Doctors Receiving Payments for AMZEEQ — Page 187
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , PA | Physician Assistant | Nutley, NJ | $8.34 | 1 |
| , PA-C | Medical | Warrendale, PA | $7.75 | 1 |
| , PA-C | Physician Assistant | Summerville, SC | $6.29 | 1 |
| , PA-C | Physician Assistant | Roswell, GA | $6.23 | 1 |
| , PA | Physician Assistant | Plano, TX | $5.39 | 3 |
| , PA-C | Medical | Hendersonville, TN | $5.35 | 1 |
| , MD | Dermatology | Verona, NJ | $4.61 | 2 |
| , D.O | Dermatology | West Orange, NJ | $4.61 | 2 |
| , DO | Dermatology | New York, NY | $4.61 | 2 |
| , PA-C | Dermatology | Chicago, IL | $4.49 | 1 |
| , MD | Dermatology | Houston, TX | $4.33 | 3 |
| , NP-C | Family | Concord Twp, OH | $3.41 | 1 |
| , M.D | Specialist | Houston, TX | $2.68 | 1 |
| , PA | Physician Assistant | West Orange, NJ | $2.09 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.3M
- Total Doctors 4,663
- Transactions 15,045
About AMZEEQ
AMZEEQ is a drug associated with $1.3M in payments to 4,663 healthcare providers, recorded across 15,045 transactions in the CMS Open Payments database. The primary manufacturer is VYNE Pharmaceuticals Inc..
Payment data is available from 2020 to 2022. In 2022, $32,525 was paid across 5 transactions to 0 doctors.
The most common payment nature for AMZEEQ is "Honoraria" ($771,720, 60.5% of total).
AMZEEQ is associated with 1 research study, including "A Prospective, Multicenter, Randomized, Evaluator-Blinded, Study to Evaluate the Safety and Efficacy of AMZEEQ Companion Treatment with Oral Isotretinoin Therapy in Patients with Moderate to Severe Acne Vulgaris" ($112,820).